Cd2Ap Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CD2AP (CD2-Associated Protein) encodes an adaptor protein that links signaling proteins to the actin cytoskeleton. Genome-wide association studies (GWAS) have identified CD2AP as a risk gene for Alzheimer's disease. The protein plays important roles in immune cell signaling, podocyte function, and has been implicated in neuronal function and neurodegeneration.
| Property | Value |
|---|---|
| Gene Symbol | CD2AP |
| Full Name | CD2 Associated Protein |
| Chromosomal Location | 6p12.3 |
| NCBI Gene ID | 9501 |
| Ensembl ID | ENSG00000198034 |
| UniProt ID | Q9Y5K7 |
| OMIM | 604332 |
| Property | Value |
|---|---|
| Protein Name | CD2AP |
| Molecular Weight | ~71 kDa (639 amino acids) |
| Subcellular Localization | Cytoplasm, cell junctions, cytoskeleton |
| Protein Family | SH3 domain-containing adaptor proteins |
| Approach | Status | Description |
|---|---|---|
| Small molecules | Research | Targeting CD2AP interactions |
| Gene therapy | Preclinical | Restoring proper splicing |
| None direct | — | No current clinical trials |
The study of Cd2Ap Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] CD2AP and Alzheimer disease. PMID:23430956
CD2AP represents a promising therapeutic target for Alzheimer's disease. Strategies to enhance CD2AP expression or function could potentially improve synaptic plasticity and reduce amyloid toxicity. Small molecules that promote CD2AP-mediated signaling are under investigation.
| Approach | Target | Stage | Indication |
|---|---|---|---|
| AAV-CD2AP | CD2AP expression | Preclinical | AD |
| CD2AP mimetics | p130Cas interaction | Discovery | AD |
| Gene therapy | CD2AP upregulation | Preclinical | FTD |
Current research focuses on understanding how CD2AP variants influence AD risk and disease progression. Studies are investigating the role of CD2AP in microglial function and immune modulation in the brain. Additionally, research is exploring how CD2AP interacts with other AD risk genes to modify disease pathology.